Growth Metrics

Varex Imaging (VREX) EBIAT (2016 - 2026)

Varex Imaging (VREX) has disclosed EBIAT for 11 consecutive years, with $2.4 million as the latest value for Q1 2026.

  • Quarterly EBIAT rose 2500.0% to $2.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$67.2 million through Jan 2026, down 39.71% year-over-year, with the annual reading at -$69.9 million for FY2025, 44.72% down from the prior year.
  • EBIAT for Q1 2026 was $2.4 million at Varex Imaging, down from $12.6 million in the prior quarter.
  • The five-year high for EBIAT was $30.7 million in Q3 2023, with the low at -$89.1 million in Q3 2025.
  • Average EBIAT over 5 years is -$2.4 million, with a median of $3.8 million recorded in 2022.
  • The sharpest move saw EBIAT tumbled 6464.29% in 2025, then skyrocketed 2500.0% in 2026.
  • Over 5 years, EBIAT stood at $3.2 million in 2022, then crashed by 115.62% to -$500000.0 in 2023, then plummeted by 10100.0% to -$51.0 million in 2024, then soared by 124.71% to $12.6 million in 2025, then crashed by 80.95% to $2.4 million in 2026.
  • According to Business Quant data, EBIAT over the past three periods came in at $2.4 million, $12.6 million, and -$89.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.